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Background: LIM domain binding protein 1 (LDB1) is a transcriptional co-factor, which interacts with multiple
transcription factors and other proteins containing LIM domains. Complete inactivation of Ldb1 in mice resulted in
early embryonic lethality with severe patterning defects during gastrulation. Tissue-specific deletions using a
conditional knockout allele revealed additional roles of Ldb1 in the development of the central nervous system,
hematopoietic system, and limbs. The goal of the current study was to determine the importance of Ldb1 function
during craniofacial development in mouse embryos.
Results: We generated tissue-specific Ldb1 mutants using Wnt1-Cre, which causes deletion of a floxed allele in the
neural crest; neural crest-derived cells contribute to most of the mesenchyme of the developing face. All examined
Wnt1-Cre;Ldb1fl/- mutants suffered from cleft secondary palate. Therefore, we performed a series of experiments to
investigate how Ldb1 regulated palate development. First, we examined the expression of Ldb1 during normal
development, and found that Ldb1 was expressed broadly in the palatal mesenchyme during early stages of palate
development. Second, we compared the morphology of the developing palate in control and Ldb1 mutant
embryos using sections. We found that the mutant palatal shelves had abnormally blunt appearance, and failed to
elevate above the tongue at the posterior domain. An in vitro head culture experiment indicated that the elevation
defect was not due to interference by the tongue. Finally, in the Ldb1 mutant palatal shelves, cell proliferation was
abnormal in the anterior, and the expression of Wnt5a, Pax9 and Osr2, which regulate palatal shelf elevation, was
also altered.
Conclusions: The function of Ldb1 in the neural crest-derived palatal mesenchyme is essential for normal
morphogenesis of the secondary palate.
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Craniofacial development begins when the cranial neural
crest cells (NCCs), which are migratory multipotent pre-
cursors, delaminate from the dorsal brain and migrate
ventro-laterally to form the mesenchyme of facial primor-
dia, known as the frontonasal prominence and pharyngeal
arches [1,2]. The frontonasal prominence develops into
the mid- and upper face, while the first pharyngeal arch* Correspondence: jj78@nyu.edu
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distribution, and reproduction in any mediumturns into the lateral skull, most of the jaw, and part of the
middle ear. The first pharyngeal arch is further divided
into maxillary arch, which is the prospective upper jaw,
and mandibular arch, which is the prospective lower jaw.
Craniofacial abnormalities are relatively common birth
defects in humans. For example, cleft palate affects 1
in ~700 births, and it can lead to serious physical (eating
difficulty, ear infection) and socio-psychological (speech,
self-esteem) problems [3-5]. The process of palate devel-
opment is very conserved between humans and mice, and
thus studies from the latter have contributed greatly to
our understanding of normal and abnormal palatogenesistral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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the frontonasal prominence and maxillary arch at the ros-
tral end of the face around embryonic day (E) 10.5 (mouse
gestation is 19 days). On the other hand, the secondary
palate develops more caudally from the medial side of the
maxillary arch. The secondary palate first appears as a
bilateral outgrowth of the palatal shelves on either side of
the tongue at ~ E11.5. Subsequently, the palatal shelves
elongate vertically, elevate themselves into a horizontal
position above the tongue, grow toward each other, and
fuse at the midline at ~ E16.5 to complete the formation
of the secondary palate. Perturbation in any of these steps
can lead to cleft palate, and a large number of genes are
involved in the tight regulation of each step [6-8].
LDB1 (LIM-domain binding protein 1, also known as
NLI and CLIM2) encodes an evolutionarily conserved
protein, found in organisms ranging from humans to
nematodes [9]. LDB1 acts as an essential cofactor for
various proteins, including LIM-domain homeodomain
transcription factors and LIM-only (LMO) proteins [9-12].
In mice, Ldb1 is ubiquitously expressed during devel-
opment, and a global knockout of Ldb1 caused mid-
gestation lethality with severe defects, such as loss of
the heart and anterior head [13]. In addition, tissue-
specific deletions using a conditional knockout allele
revealed that Ldb1 is important in the development
of the central nervous system (CNS), hematopoietic
system, and limbs at later stages [14-16].
To elucidate the potential role of Ldb1 in craniofacial
development, we generated a tissue-specific Ldb1 mutant
using Wnt1-Cre, which causes gene deletion in neural
crest-derived cells [17,18]. We discovered that Ldb1 plays
an essential role in the morphogenesis of the secondary
palate.Figure 1 Expression of Ldb1 during palate development. (A-H)
Coronal sections of the heads were processed by RNA in situ
hybridization for Ldb1, using a probe against exons 5–9. Ldb1fl/-
embryos were used as controls in this figure. Brackets in A, oral half
of the first pharyngeal arch (PA1). Arrows in E and G, condensed
dental mesenchyme. Abbreviations: LM, lower molar; mdPA1,
mandibular arch; mxPA1, maxillary arch; PS, palatal shelf; To, tongue;
UM, upper molar. Bar, 0.5 mm.Results
Expression of Ldb1 during craniofacial development
Although Ldb1 is broadly expressed during development,
it is not expressed at the same level everywhere. Therefore,
we examined the expression of Ldb1 during craniofacial
development at E10.5 - E14.5, focusing on the developing
palate. Prior to the current study, the information on the
facial expression of Ldb1 was available only at E10.5 [19].
For RNA in situ hybridization, we used an anti-sense
probe against exons 5 through 9 of Ldb1, which are floxed
in the conditional knockout allele [14]. We simultan-
eously performed in situ hybridization on the sections
from control (Ldb1fl/-) and Wnt1-Cre;Ldb1fl/- mutant em-
bryos. This strategy allowed us to distinguish low levels of
Ldb1 transcript from non-specific background (because
the former should disappear upon Cre-mediated deletion),
and to verify efficient inactivation of Ldb1 in the facial
mesenchyme by Wnt1-Cre.At E10.5, which is just before palate development
begins, Ldb1 was expressed broadly and strongly in the
first pharyngeal arch mesenchyme in control embryos
(Figure 1A). The mesenchymal expression of Ldb1 was
moderately higher in the oral half (brackets in Figure 1A)
than in the aboral half, consistent with the positive regu-
lation of Ldb1 expression by FGF8 from the oral ecto-
derm [19]. Contrary to the earlier report [19], we also
detected the expression of Ldb1 in the epithelium of the
first pharyngeal arch, although at a lower level than in
the mesenchyme (Figure 1A).
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relative intensity of Ldb1 expression in the mesenchyme
compared with in the epithelium (Figure 1C-H). At
E13.5 and E14.5, the expression in the mesenchyme was
barely detectable except in the condensed dental mesen-
chyme (arrows in Figure 1E,G), whereas the expression
in the epithelium, including the developing teeth, became
more pronounced (Figure 1E-H). Throughout the stages
examined, there was no obvious difference in the expres-
sion of Ldb1 along the antero-posterior axis of the face
(Additional file 1: Figure S1).
We confirmed that Wnt1-Cre caused deletion of Ldb1
in most of the facial mesenchyme, except in a small,
scattered group of cells (Figure 1B,D,F,H). This is con-
sistent with the presence of mesoderm-derived cells in
the mesenchyme [20].Neural crest-specific inactivation of Ldb1 leads to cleft
secondary palate
We found that all of the Wnt1-Cre;Ldb1fl/- mutants had
fully cleft secondary palate at birth (Figure 2A,B; N = 8).
Skeletal preparations of the mutants showed no gross
abnormality in the facial structures, apart from the defects
in the maxilla and palatine bone associated with the cleft
palate phenotype (Figure 2C-F). Consistent with the idea
that the development of the face was not broadly affected
in the Wnt1-Cre;Ldb1fl/- mutants, they appeared indistin-
guishable from control embryos at E10.5, with neural
crest-derived cells showing normal distribution in all of
the facial primordia (Additional file 1: Figure S2).Figure 2 Cleft secondary palate of Wnt1-Cre;Ldb1fl/- mutants. All the sa
toward the top. C-F) Skeleton staining for bone (red) and cartilage (blue). C
after the removal of the lower jaw, in the same orientation as in A and B. N
E because they are underneath the maxilla (Max) and palatine (PL) normall
frontal bone; LO, lamina obturans; Pa, parietal bone; PMx, premaxilla; Pt, pteLdb1-mutant palatal shelves have abnormal morphology
and are impaired in reorientation
To determine which aspect of palatogenesis was disrupted
inWnt1-Cre;Ldb1fl/- mutants, we examined the morphology
of the mutant palate at various stages. We examined three
positions along the antero-posterior axis of the palate,
because there is heterogeniety in the genetic regulation of
palate development along this axis. We found that from
E13.5, the mutant palatal shelf had an abnormal shape in
that it was more blunt and wider at the bottom compared
with the controls (Figure 3A-F); this was more pro-
nounced in the anterior and middle levels than in the
posteior level (Figure 3A-D, arrows). The size of the mu-
tant palatal shelves, measured as the area on the sections,
was not significantly different from the controls at E13.5
(Figure 3A-F,S). However, from E14.5, the mutant palatal
shelves were smaller than the controls in the anterior and
posterior palate (Figure 3G-L,T). In addition, the re-
orientation of the palatal shelf was impaired in Wnt1-Cre;
Ldb1fl/- mutants; at E14.5, the anterior palate was elevated
above the tongue in both controls and Ldb1 mutants
(Figure 3G,H). However, the middle palate and the poster-
ior palate remained vertical in the mutants at this stage
(Figure 3J,L). Just before the birth (E18.5), the mutant
middle palate appeared to have initiated the re-orientation
as indicated by the medial protrusion (arrow in Figure 3P),
which is considered an intermediate structure for palatal
shelf elevation [21,22]. On the other hand, the posterior
palate failed to elevate even at this late stage (Figure 3R).
Tissue sections also revealed that Wnt1-Cre;Ldb1fl/- mu-
tants had abnormal dentition, including loss of molars andmples are E18.5. A,B) Whole mount view of the palate. The nose is
and D are lateral views of the head. E and F show the palate area
ote that the vomer (Vo) and presphenoid (PSp) in F are not visible in
y. Abbreviations: BO, basioccipital; BS, basisphenoid; De, dentary; Fr,
rygoid. Bar, 1 mm.
Figure 3 Morphological and morphometric analyses of the palate in Wnt1-Cre;Ldb1fl/- mutants. A-R) Coronal sections of the heads were
stained with cresyl violet. Arrows in A-D, the distal tip of the palatal shelf. Arrow in P, a protrusion on the medial side of the palatal shelf,
considered an intermediate structure for palatal shelf elevation. Abbreviation: DT, diastema tooth. Bar, 0.5 mm. S and T) Quantitative analysis of
the area of the palatal shelf. The boundary of the palatal shelf used for this measurement is indicated by the dotted lines in A-L. *: p < 0.05.
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opmental arrest of lower molars. The details of the tooth
phenotype will be described elsewhere.
Defects intrinsic to the palate are responsible for failed
elevation of Ldb1-mutant posterior palate
Multiple mouse mutants had been reported to have de-
fects in palatal shelf elevation (see Discussion for de-
tails). One of the common causes of a failure in palatal
shelf elevation is the interference by the tongue, when
the tongue is not sufficiently depressed within the oral
cavity. We noticed that the tongue of Wnt1-Cre;Ldb1fl/-
mutants was abnormally tall (Figure 3L,R). Therefore,
we asked whether the defect in palatal shelf elevation
was secondary to the tongue phenotype.
To answer this question, we dissected embryos at E13.5,
before the palatal shelves were elevated. We removed the
tongue and the lower jaw from their heads, and cultured
the heads rotating in a culture tube for 3 days. In all of the
control embryos, one or both of the palatal shelves be-
came horizontal throughout the antero-posterior axis after
the culture (Figure 4A,B,E,F,I,K,M; N = 10). In contrast, inall of the Ldb1-mutant embryos, both palatal shelves
remained vertical in the middle and posterior domains
(Figure 4C,D,G,H,L,N; N = 8). The mutant anterior palate
was horizontal after the culture (Figure 4J), which is
consistent with the in vivo finding (Figure 3). Hence, we
concluded that the defect in middle/posterior palatal
shelf elevation in Wnt1-Cre;Ldb1fl/- mutants is not due
to the mechanical hindrance by the tongue.
Localized abnormality in cell proliferation in Wnt1-Cre;
Ldb1fl/- mutant palatal shelves
Since the palatal shelves of Wnt1-Cre;Ldb1fl/- mutants were
moderately smaller than the controls at E14.5 (Figure 3T),
we asked whether a change in cell proliferation or cell
death could explain this phenotype.
We labeled proliferating cells with bromodeoxyuridine
(BrdU) at E13.5, performed immunofluorescence with anti-
BrdU antibody on sections, and calculated the percentage
of mitotic cells in the palate mesenchyme (Figure 5). The
sections of the palatal shelves were divided into medial and
lateral areas (Figure 5A-F), and the mitotic index was calcu-
lated for each area and for the total area (Figure 5G,H,I).
Figure 4 Removing the lower jaw does not restore the reorientation of the palatal shelves in Wnt1-Cre;Ldb1fl/- mutants. The upper jaw
region from E13.5 embryos, before culture (A-D) and after 3-day culture in the absence of the lower jaw and the tongue (E-N). A-H are fluorescent
pictures of the heads processed by whole mount DAPI staining. (A,C,E,G) Intra-oral views directly into the palate. (B,D,F,H) Oblique views showing the
profile of the palatal shelf. Red arrows in F and H point to the posterior palatae. (I-N) Coronal sections were stained with Nuclear Fast Red.
Abbreviations: ant, anterior; pos, posterior; No, nose. Bar, 0.5 mm.
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Ldb1fl/- mutants, the only statistically significant difference
(p < 0.05) was found in the medial area of the anterior pal-
ate; this region showed reduced cell proliferation in the
mutants (Figure 5G). Although the lateral area of the an-
terior palate had higher average mitotic index in the mu-
tants than in controls, this difference was not statistically
significant (Figure 5H). When the total area of the palatal
shelf was considered, there was no significant difference in
cell proliferation at any position along the anterio-
posterior axis (Figure 5I). Together, we conclude that the
small decrease in the cell proliferation in the anterior-
medial palate contributed to the hypoplasia of this region
in Wnt1-Cre;Ldb1fl/- mutants (Figure 3).
We also stained the palate sections with an antibody
against cleaved caspase-3, to label apoptotic cells. There
were very few dying cells in the palate mesenchyme of
both controls and Ldb1 mutants, and no difference
was apparent between the genotypes (Additional file 1:
Figure S3).
Expression of Wnt5a, Osr2 and Pax9, which regulate
palatal shelf elevation, is altered in the Ldb1-mutant
palate
Since LDB1 serves as a cofactor for multiple transcrip-
tion factors, it is likely that LDB1 regulates the expres-
sion of other genes in the developing palate. Therefore,
we asked whether the inactivation of Ldb1 leads to a
change in the expression of genes important for palate
development. In particular, we focused on the genes
that are involved in reorientation of the palatal shelf,the process most affected in Wnt1-Cre;Ldb1fl/- mutants.
Wnt5a, Osr2, Pax9 and Zfhx1a have been implicated in
palatal shelf elevation because the mutation of each
gene in mice led to delay or failure in elevation [23-27].
Pdgfra, expressed in the palatal mesenchyme, is also
important in palatal shelf elevation as indicated by the
delayed elevation in mouse mutants of Pdgfc, encoding
a ligand for Pdgfra [28].
We found changes in the expression of Wnt5a, Osr2
and Pax9 in Wnt1-Cre;Ldb1fl/- mutant palate. WNT5A
was shown to regulate cell migration in the palatal shelf;
specifically, it attracted mesenchyeme cells [23]. During
normal palatogenesis, Wnt5a is expressed strongly in the
anterior palate but minimally in the posterior palate at
E13.5 (Figure 6A,C,E). However, in the Ldb1 mutants,
there was ectopic expression of Wnt5a at the distal tip
of the posterior palatal shelf (arrows in Figure 6E,F).
Chemoattraction of the palatal mesenchyme cells toward
this location could disrupt elevation of the palatal
shelves (see Discussion). Osr2 is normally expressed with
asymmetric intensity in the anterior and middle palate,
weaker on the nasal side and the distal tip of the palatal
shelf (arrows in Figure 6G,I), and stronger on the oral
side (Figure 6G,I [24]). In the Ldb1 mutants, Osr2 ex-
pression was up-regulated in the distal tip of the anterior
and middle palate (arrows in Figure 6G-J). On the other
hand, Pax9 was down-regulated in the Ldb1 mutants in
the distal tip (arrows in Figure 6M-R) and the nasal side
of the middle palate (Figure 6O,P). The expression pat-
terns of Zfhx1a and Pdgfra were normal in Wnt1-Cre;
Ldb1fl/- mutant palate (Additional file 1: Figure S4).
Figure 5 Cell proliferation analysis. (A-F) Coronal sections of the heads from E13.5 embryos were processed with immunofluorescence for
BrdU (red) and counter-stained with DAPI for nuclei (blue). (G-H) Quantitative analyses of the mitotic index in the palatal shelf, in the medial (M),
lateral (L) or combined (I) areas as demarcated by white lines in A-F. *, p > 0.05. Bar, 0.2 mm.
Almaidhan et al. BMC Developmental Biology 2014, 14:3 Page 6 of 10
http://www.biomedcentral.com/1471-213X/14/3Discussion
In this paper, we investigated the role of Ldb1 in mamma-
lian craniofacial development. LDB1 can bind to various
proteins, including 12 LIM-domain homeodomain tran-
scription factors and 4 LIM only (LMO) proteins in mam-
mals, and is thought to act as a cofactor modulating the
activities of these proteins [9]. Although Ldb1 was shown
to play crucial roles in neuronal differentiation in the brain
and spinal cord, erythropoiesis, and limb development
[9,14-16], its importance in craniofacial development had
been unknown. We found that the function of LDB1 is
essential for normal development of the secondary palate,
in particular, for the reorientation of the palatal shelves.
The details of the molecular and cellular processes of
palatal shelf elevation remain to be elucidated, but it is
thought to involve two mechanisms: a rapid “swinging”
of the palatal shelf from vertical to horizontal position isa favored model for the anterior palate, whereas tissue
remodeling involving the “flow” of the cells from the ven-
tral to the medial side of the palatal shelf is supported by
histological studies in the posterior palate [21,22]. In case
of Wnt1-Cre;Ldb1fl/- mutants, the anterior palate elevated
normally while the posterior palate failed to elevate, even
though the anterior palate suffered from more severe
growth deficiency than the posterior palate. Therefore, our
result supports the notion that two distinct mechanisms
regulate the reorientation of the palatal shelf along the
antero-posterior axis, and indicates that only the mechan-
ism for the posterior palate was affected in Wnt1-Cre;
Ldb1fl/- mutants.
Palatal defects have been described in mouse mutants of
more than 100 genes, and the delay or failure in palatal
shelf elevation was noted in many of them [6,7,29]. Inacti-
vation of Pdgfc, Osr2, Pax9, Zfhx1a, and Adamts20 caused
Figure 6 Altered expression of Wnt5a, Osr2 and Pax9 in Wnt1-Cre;Ldb1fl/- mutant palatal shelf. (A-R) Coronal sections of the heads from
E13.5 embryos were processed by RNA in situ hybridization. Arrows in E and F, ectopic expression of Wnt5a in the posterior palate. Arrows in G-J,
up-regulation of Osr2 in the distal tip of the Ldb1 mutant palatal shelf. Arrows in M-R, down-regulation of Pax9 in the Ldb1 mutant palatal shelf.
Abbreviations: na, nasal domain of the palatal shelf; or, oral domain of the palatal shelf. Bar, 0.2 mm.
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function of Fgfr2 and Bmpr1a [24-28,30-32]. On the other
hand, inactivation of Jag2, Fgf10, Spry2, Wnt5a, Gsk3b,
Tbx1, Tak1 and Fgfr1 led to failure in palatal shelf eleva-
tion, at least within the developmental stages examined
in each study [23,33-41]. We found that the posterior
palate of Wnt1-Cre;Ldb1fl/- mutants remained vertical up
to E18.5, the last stage when we can collect the mutants
because they die shortly after birth, and thus the pheno-
type was a failure rather than a delay of posterior palatal
shelf elevation.
Among the examples with failed elevation of palatal
shelves, the mutants for Jag2, Fgf10, and Tbx1 showed
abnormal fusion between the palatal epithelium and oral
or tongue epithelium, which likely contributed the defect
[33,34,38]. In Tak1 mutants, the palate defect was due
to the mechanical hindrance by the malformed tongue
[39,41]. In contrast, in the mutants of Wnt5a, Spry2,
Gsk3b, and Fgfr1, the palatal elevation defect was attrib-
uted to changes intrinsic to the palatal shelves, includ-
ing abnormal levels of cell proliferation and cell death
[23,36,37,40]. Furthermore, Wnt5a mutation affected
migration of the mesenchyme cells in the palatal shelf;
He et al. [23] demonstrated that there was directional
migration of the cells in the developing palate, and that
WNT5A acted as a chemoattractant for palatal mesen-
chyme cells.
In the current study, we ruled out the interference by
the tongue as a cause of the palate defect in Wnt1-Cre;
Ldb1fl/- mutants. We did not find evidence of aberrant ad-
hesion between the Ldb1 mutant palatal shelf and the
tongue or oral epithelium. Although there was a localized
decrease in the cell proliferation in Wnt1-Cre;Ldb1fl/- mu-
tant palate, it was only found in the anterior palate, whichdid not exhibit reorientation defect. On the other hand,
we did find ectopic expression of Wnt5a at the distal tip
of the posterior palatal shelf in Wnt1-Cre;Ldb1fl/- mutants.
This ectopic WNT5A could pull the palatal mesenchyme
cells toward the distal end of the palatal shelf, preventing
the cells from “flowing” to the medial side, which is
thought to be integral to the reorientation of the palatal
shelves in the posterior domain. Further experiments are
necessary to test this hypothesis.
The up-regulation of Osr2 and down-regulation of Pax9
could also contribute to the palatal defect of the Ldb1 mu-
tants. However, the changes in Osr2 and Pax9 expression
were more pronounced in the middle palate than in the
posterior palate, and thus did not correlate with the rela-
tive severities of the elevation defect. Furthermore, while
the morphologies of the anterior and middle palate are
very similar between Pax9−/− mutants and Wnt1-Cre;
Ldb1fl/- mutants (such as the absence of the indentation
medial to the upper molar) [26,27], the phenotypes differ
in the posterior palate. In Pax9−/− mutants, the posterior
palate became horizontal by E15.5, indicating that there
is a delay but not a failure in palatal elevation [27]. Also,
Pax9−/− mutants showed a significant decrease in cell
proliferation in the posterior palate at E13.5, and conse-
quently, suffered from much more severe hypoplasia of
this region than Wnt1-Cre;Ldb1fl/- mutants at E14.5 [27].
Therefore, it is possible that the delay in palatal elevation
in Pax9−/− mutants is secondary to growth deficiency,
whereas in Wnt1-Cre;Ldb1fl/- mutants, the process of pal-
atal elevation is directly affected.
Among the LIM domain proteins, LHX6 and LHX8
play important roles in the development of the second-
ary palate, and thus they are the most likely partners of
LDB1 for its role in palatogenesis. Mutation of Lhx8 in
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trance, in which the horizontal growth and/or fusion of
the palatal shelves were affected [42]. Although inactiva-
tion of Lhx6 did not cause overt palatal defects [43],
simultaneous inactivation of Lhx6 and Lhx8 resulted in
fully penetrant cleft palate, indicating that the two genes
have overlapping functions [44].
Conclusions
We established that Ldb1 in the facial mesenchyme is es-
sential for normal development of the secondary palate.
Inactivation of Ldb1 resulted in changes intrinsic to the
palatal shelves that led to the failure in reorientation of the
posterior palate. In addition, our results suggest that LDB1
is involved in regulating the expression of Wnt5a, Osr2




All the experiments involving animals were performed
with the approval from New York University Institutional
Animal Care and Use Committee. Wnt1-Cre, Ldb1+/− and
Ldb1fl/fl mice have been described [13,14,17]. The tissue-
specific Ldb1 mutant embryos (Wnt1-Cre;Ldb1fl/-) were
obtained from the crosses between Ldb1fl/fl and Wnt1-Cre;
Ldb1+/−. The embryos were genotyped by PCR using
DNA from the tail. Littermates of all the other genotypes
from the above cross were indistinguishable from wild
type embryos, and thus they were used as controls without
distinction unless otherwise specified.
Skeleton staining, Cresyl Violet staining, RNA in situ
hybridization
For skeleton staining, the skin was removed from E18.5
embryos, and the skeleton was stained with Alcian blue
and Alizarin red as described previously [43]. To prepare
frozen sections, the embryos were fixed in 4% paraformal-
dehyde in PBS overnight, washed with PBS, and cryopro-
tected in 10% sucrose for 1 day then in 20% sucrose for 1
day, and embedded in OCT (Tissue-tek). The sections
were prepared at 12 μm~ 20 μm depending on the age of
the embryo. All the sections used in this study are in the
coronal plane. The frozen sections were stained with 0.1%
cresyl violet solution as described [43] to visualize tissue
morphology. For RNA in situ hybridization, the frozen
sections were hybridized with Digoxigenin-labeled RNA
probes as described [43].
Morphometric analysis of the size of the palatal shelf
The area of the palatal shelf was measured from the
photographs of cresyl violet-stained sections using ImageJ
program as described [43]. Two palatal shelves were mea-
sured from each embryo, and measurements from threemutants and three controls were used for statistical
analysis (Student’s t-test).
Detection of cell proliferation and apoptosis
To detect proliferating cells, a pregnant female was injected
intraperitoneally with BrdU solution (Invitrogen) 2 hours
before harvesting embryos at E13.5. Immunofluorescence
with anti-BrdU antibody (Abcam, rat monoclonal, 1:200)
was performed following the manufacturer’s protocol, and
DAPI was used to stain nuclei. To calculate the percentage
of dividing cells, we first counted the total number of nuclei
in a defined area from DAPI images, by automated count-
ing using ImageJ plug-in followed by manual confirmation.
Then the number of BrdU-positive cells from the same
area was counted manually, and this number was di-
vided by the total number of nuclei. The palatal shelf
was divided into medial and lateral domains on the cor-
onal sections, by a vertical line drawn from the mid-
point of the border that separates the palatal shelf and
the rest of the upper jaw (see Figure 5A-F). Two palatal
shelves from each embryo, and three mutant and three
control embryos were analyzed. Student’s t-test was used
to determine whether the difference was statistically sig-
nificant (= p < 0.05). To detect apoptotic cells, immuno-
fluorescence with anti-caspase3 antibody (Cell Signaling
Technology) was performed as previously described [43].
Culture of the palate in rotating tubes
The embryos were dissected at E13.5 and decapitated in
PBS, and the lower jaw and the top of the head (calvaria
region) were further removed. The remaining upper jaw re-
gion was placed in a glass culture tube with 1.5 ml of CO2-
independent medium (Life Technologies) supplemented
with 20% fetal bovine serum and antibiotics-antimycotics
(Life Technologies), and cultured on a rotisserie inside a
37°C incubator. After 3 days, the upper jaw was rinsed with
PBS and fixed with 4% paraformaldehyde, and processed
for frozen sectioning as described above, or for whole-
mount DAPI staining following a published protocol [45].
Additional file
Additional file 1: Figure S1. Expression of Ldb1 during palate
development. Coronal sections of the heads were processed by RNA in
situ hybridization for Ldb1, using a probe against exons 5–9. Ldb1fl/-
embryos were used as controls in this figure. Abbreviations: DT, diastema
tooth; LM, lower molar; mdPA1, mandibular arch; mxPA1, maxillary arch;
PS, palatal shelf; To, tongue; UM, upper molar. Bar, 0.5 mm. Figure S2.
Distribution of neural crest-derived cells in the developing face. The
neural crestderived cells (green) were visualized using Wnt1-Cre and
R26REYFP reporter system [18]. The exact genotypes of the embryos are
Wnt1-Cre;Ldb1fl/+;R26REYFP/+ for the control and Wnt1-Cre;Ldb1fl/-;
R26REYFP/+ for the mutant. The distribution of neural crest-derived cells
appeared normal in the mutant. Bar, 0.5 mm. Figure S3. Detection of
apoptotic cells in the palatal shelf. Coronal sections of the heads from
E13.5 embryos were processed with immunofluorescence for cleaved
caspase 3 (red) and counter-stained with DAPI for nuclei (blue). The white
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in the palate in the embryos of either genotype. Bar, 0.5 mm. Figure S4.
Expression of Zfhx1a and Pdgfra. Coronal sections of the heads from
E13.5 embryos were processed by RNA in situ hybridization. The
expression of Zfhx1a and Pdgfra was not altered in Wnt1-Cre;Ldb1fl/-
mutant palatal shelf. Bar, 0.2 mm.
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